14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $64.33 $72.17 Friday, 3rd May 2024 GILD stock ended at $64.78. This is 0.84% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 1.87% from a day low at $64.33 to a day high of $65.53.
90 days $64.33 $77.87
52 weeks $64.33 $87.86

Historical Gilead Sciences prices

Date Open High Low Close Volume
Mar 30, 2023 $81.78 $81.90 $81.06 $81.45 3 822 761
Mar 29, 2023 $81.26 $81.97 $80.93 $81.29 5 469 272
Mar 28, 2023 $79.96 $81.11 $79.79 $80.97 4 154 848
Mar 27, 2023 $80.38 $80.99 $79.41 $79.58 4 444 905
Mar 24, 2023 $78.93 $80.40 $78.33 $80.00 4 805 534
Mar 23, 2023 $77.78 $78.93 $77.64 $78.76 5 015 561
Mar 22, 2023 $79.10 $79.38 $77.76 $77.81 4 908 875
Mar 21, 2023 $79.53 $80.05 $78.36 $79.14 4 744 674
Mar 20, 2023 $77.71 $79.68 $77.63 $79.46 4 672 644
Mar 17, 2023 $79.76 $79.76 $76.53 $77.31 16 827 096
Mar 16, 2023 $79.18 $79.97 $78.42 $79.85 7 274 441
Mar 15, 2023 $79.10 $79.89 $78.51 $79.65 4 875 371
Mar 14, 2023 $79.03 $79.91 $78.32 $79.77 5 497 719
Mar 13, 2023 $78.57 $81.27 $78.57 $79.51 6 844 950
Mar 10, 2023 $79.02 $80.31 $78.90 $79.50 6 146 811
Mar 09, 2023 $80.57 $80.70 $78.29 $78.95 7 024 366
Mar 08, 2023 $80.50 $80.83 $79.82 $80.20 3 850 792
Mar 07, 2023 $81.30 $81.30 $79.94 $80.28 6 106 422
Mar 06, 2023 $81.11 $81.34 $80.54 $81.11 4 499 159
Mar 03, 2023 $79.81 $81.18 $79.59 $81.07 4 914 767
Mar 02, 2023 $79.51 $79.90 $79.21 $79.62 3 458 374
Mar 01, 2023 $80.34 $80.34 $79.39 $79.59 5 206 768
Feb 28, 2023 $80.81 $80.93 $79.92 $80.53 5 746 597
Feb 27, 2023 $81.16 $81.31 $80.58 $80.89 4 928 951
Feb 24, 2023 $82.27 $82.30 $80.33 $80.66 6 288 960
Click to get the best stock tips daily for free!

About Gilead Sciences

Gilead Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V... GILD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT